MarketCap
Facebook
X
TelegramQuarterly report 2023-Q3
added 11-08-2023
Invitae Corporation Long Term Debt Current 2011-2026 | NVTA
Annual Long Term Debt Current Invitae Corporation
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 14.6 M | 12.4 M | 8.79 M | 4.87 M | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 14.6 M | 4.87 M | 10.2 M |
Long Term Debt Current of other stocks in the Diagnostics research industry
| Issuer | Long Term Debt Current | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Akumin
AKU
|
17.2 M | - | -17.87 % | $ 25.9 M |  Canada |
|
Centogene N.V.
CNTG
|
2.18 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Brainsway Ltd.
BWAY
|
824 K | $ 24.33 | 5.28 % | $ 99.4 M |  Israel |
 |
Chembio Diagnostics
CEMI
|
915 K | - | 0.22 % | $ 16.8 M |  USA |
 |
Check-Cap Ltd.
CHEK
|
264 K | - | - | $ 9.42 M | Israel |
 |
Biocept
BIOC
|
518 K | - | -13.05 % | $ 7.29 M | USA |
 |
Castle Biosciences
CSTL
|
1.66 M | $ 39.7 | 0.92 % | $ 1.1 B | USA |
 |
Co-Diagnostics
CODX
|
838 K | $ 6.0 | -3.07 % | $ 176 M | USA |
 |
Accelerate Diagnostics
AXDX
|
829 K | - | -61.36 % | $ 2.46 M | USA |
 |
DermTech
DMTK
|
3.07 M | - | -11.32 % | $ 2.94 M | USA |
 |
DexCom
DXCM
|
21.1 M | $ 70.68 | 4.87 % | $ 27.3 B | USA |
 |
BioNano Genomics
BNGO
|
2.99 M | $ 1.58 | - | $ 2.01 M | USA |
 |
Guardant Health
GH
|
29.2 M | $ 107.76 | -2.19 % | $ 13.2 B | USA |
 |
Global Cord Blood Corporation
CO
|
147 K | - | - | $ 399 M |  China |
 |
Genetic Technologies Limited
GENE
|
264 K | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
21.5 M | - | 0.12 % | $ 80.1 M | China |
 |
Illumina
ILMN
|
79 M | $ 145.25 | 2.96 % | $ 23.1 B | USA |
 |
IQVIA Holdings
IQV
|
99 M | $ 241.11 | -0.55 % | $ 43.7 B | USA |
 |
CareDx, Inc
CDNA
|
5.94 M | $ 20.41 | 19.15 % | $ 1.1 B | USA |
 |
Danaher Corporation
DHR
|
173 M | $ 238.83 | 0.2 % | $ 175 B | USA |
 |
Celcuity
CELC
|
172 K | $ 104.34 | -2.95 % | $ 4.12 B | USA |
 |
DarioHealth Corp.
DRIO
|
111 K | $ 11.97 | -1.56 % | $ 340 M | Israel |
 |
Anixa Biosciences
ANIX
|
41 K | $ 3.19 | -5.62 % | $ 102 K | USA |
 |
Enzo Biochem
ENZ
|
841 K | - | -8.98 % | $ 14.8 K | USA |
 |
Lantheus Holdings
LNTH
|
1.87 M | $ 67.28 | -0.41 % | $ 4.66 B | USA |
 |
Exact Sciences Corporation
EXAS
|
27.4 M | $ 102.23 | 0.11 % | $ 18.9 B | USA |
 |
Fulgent Genetics
FLGT
|
1.44 M | $ 28.16 | 1.11 % | $ 851 M | USA |
 |
Medpace Holdings
MEDP
|
23.3 M | $ 599.7 | 0.79 % | $ 18.6 B | USA |
 |
Aspira Women's Health
AWH
|
77 K | - | -6.19 % | $ 10.5 M | USA |
 |
Motus GI Holdings
MOTS
|
169 K | - | -34.28 % | $ 263 K | Israel |
 |
Myriad Genetics
MYGN
|
12.8 M | $ 6.56 | -0.3 % | $ 594 M | USA |
 |
Charles River Laboratories International
CRL
|
54.2 M | $ 219.73 | -0.62 % | $ 11.3 B | USA |
 |
Heska Corporation
HSKA
|
2.94 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
475 K | - | -20.0 % | $ 1.06 M | USA |
 |
National Research Corporation
NRC
|
2.68 M | $ 20.3 | 2.94 % | $ 498 M | USA |
 |
Mettler-Toledo International
MTD
|
29.8 M | $ 1 486.95 | 0.1 % | $ 31.6 B |  Schweiz |
 |
Natera
NTRA
|
7.64 M | $ 233.65 | -0.28 % | $ 23 B | USA |
 |
ENDRA Life Sciences
NDRA
|
96.9 K | $ 4.51 | -3.01 % | $ 2.42 M | USA |
 |
Neogen Corporation
NEOG
|
5.64 M | $ 9.33 | -3.01 % | $ 2.02 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
173 M | $ 175.05 | 0.34 % | $ 19.4 B | USA |
|
Biodesix
BDSX
|
719 K | $ 8.2 | 50.18 % | $ 1.06 B | USA |
 |
Organovo Holdings
ONVO
|
521 K | - | -2.3 % | $ 19.4 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
185 M | $ 249.91 | -0.75 % | $ 21 B | USA |
 |
ICON Public Limited Company
ICLR
|
24.3 M | $ 180.43 | -0.52 % | $ 14.9 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
21.5 M | $ 722.17 | 1.24 % | $ 59.6 B | USA |